Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Net Margin (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Net Margin for 16 consecutive years, with 2.58% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 469.0% year-over-year to 2.58%, compared with a TTM value of 12.18% through Dec 2025, up 179.0%, and an annual FY2025 reading of 12.18%, up 225.0% over the prior year.
  • Net Margin was 2.58% for Q4 2025 at Orthofix Medical, up from 9.94% in the prior quarter.
  • Across five years, Net Margin topped out at 24.02% in Q4 2022 and bottomed at 34.78% in Q1 2023.
  • Average Net Margin over 5 years is 10.52%, with a median of 9.6% recorded in 2023.
  • The sharpest move saw Net Margin crashed -3358bps in 2021, then soared 4695bps in 2022.
  • Year by year, Net Margin stood at 22.93% in 2021, then surged by 205bps to 24.02% in 2022, then crashed by -139bps to 9.25% in 2023, then grew by 21bps to 7.27% in 2024, then soared by 64bps to 2.58% in 2025.
  • Business Quant data shows Net Margin for OFIX at 2.58% in Q4 2025, 9.94% in Q3 2025, and 7.36% in Q2 2025.